| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.83B | 47.10B | 54.35B | 52.36B | 45.66B | 44.82B |
| Gross Profit | 3.27B | 3.13B | 4.43B | 5.93B | 5.93B | 7.49B |
| EBITDA | 2.86B | 2.47B | 3.58B | 6.19B | 6.48B | 7.92B |
| Net Income | -2.68B | -3.28B | -1.03B | 1.30B | 2.00B | 2.51B |
Balance Sheet | ||||||
| Total Assets | 56.41B | 55.72B | 51.74B | 48.95B | 46.74B | 44.73B |
| Cash, Cash Equivalents and Short-Term Investments | 6.78B | 6.57B | 5.99B | 6.13B | 6.43B | 9.35B |
| Total Debt | 27.23B | 25.08B | 18.34B | 14.96B | 13.26B | 14.96B |
| Total Liabilities | 38.15B | 36.11B | 29.98B | 26.58B | 25.66B | 27.11B |
| Stockholders Equity | 16.70B | 17.94B | 19.91B | 20.41B | 18.21B | 14.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -7.33B | -2.64B | -446.00M | -605.00M | 6.03B |
| Operating Cash Flow | 0.00 | 1.26B | 3.90B | 4.91B | 2.98B | 8.74B |
| Investing Cash Flow | 0.00 | -6.46B | -5.96B | -5.22B | -3.93B | -2.52B |
| Financing Cash Flow | 0.00 | 5.39B | 1.95B | -174.00M | -2.92B | -6.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥6.66B | 8.95 | ― | 2.64% | 2.28% | 41.72% | |
68 Neutral | ¥4.11B | 19.34 | ― | 4.39% | 9.38% | 0.07% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥3.78B | -31.23 | ― | ― | -9.58% | ― | |
58 Neutral | ¥5.29B | 13.65 | ― | 4.51% | 0.61% | -453.99% | |
57 Neutral | ¥6.75B | -15.41 | ― | 3.44% | -7.72% | -311.30% | |
54 Neutral | ¥5.32B | -3.50 | ― | 0.93% | -5.00% | 22.33% |